Sie befinden sich hier: Mitarbeiter > publist

PD Dr. med. Sascha Gerdes
Aktuelle Publikationen


Keine Einträge


Küster D, Nast A, Gerdes S, Weberschock T, Wozel G, Gutknecht M, Schmitt J.
Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting.
Arch Dermatol Res 2016;308(4):249-61
Online weight-loss coaching for patients with psoriasis: results of a pilot study.
Gerdes S, Dethlefs B, Personke Y, Storim J, Mrowietz U.
Br J Dermatol 2016;174(3):674-6
Gottlieb AB, Lacour JP, Korman N, Wilhelm S, Dutronc Y, Schacht A, Erickson J, Zhang L, Mallbris L, Gerdes S
Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies.
J Eur Acad Dermatol Venereol 2016;[Epub ahead of print]
Griffiths CE, Thaçi D, Gerdes S, Arenberger P, Pulka G, Kingo K, Weglowska J; EGALITY study group., Hattebuhr N, Poetzl J, Woehling H, Wuerth G, Afonso M
The EGALITY study: A confirmatory, randomised, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, versus the originator product in patients with moderate to severe chronic plaque-type psoriasis.
Br J Dermatol. 2016;[Epub ahead of print]
Mrowietz U, Gerdes S, Gläser R, Schröder O.
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Acta Derm Venereol. 2016;97(2):283-4
Albrecht J, Gerdes S
A new option on the horizon for the treatment of psoriasis: it is needed, but not at any price.
Br J Dermatol. 2016;174(6):1183-4
Gerdes S, Mrowietz U, Boehncke WH
Comorbidity in psoriasis
Hautarzt 2016;67(6):438-44
Wilsmann-Theis D, Gerdes S
Topische Therapie der Psoriasis
UNI-MED 2016;


Wilsmann-Theis D, Frambach Y, Philipp S, Weyergraf AJ, Jacobi A, Mössner R, Gerdes S.
Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Dermatology 2015;230(2):119-27


Steinz K, Gerdes S, Domm S, Mrowietz U.
Systemic treatment with fumaric Acid esters in six paediatric patients with psoriasis in a psoriasiscentre.
Dermatology 2014;229(3):199-204
Steinz K, Schubert S, Harder J, Gerdes S, Mrowietz U, Gläser R.
Bacterial soft tissue infection in psoriasis despite induction of epidermal antimicrobial peptides.
Exp. Dermatol. 2014;23(11):862-4
Mrowietz U, Steinz K, Gerdes S.
Psoriasis: to treat or to manage?
Exp Dermatol. 2014;23(10):705-9
Gerdes S, Laudes M, Neumann K, Baurecht H, Mrowietz U.
Wnt5a - a potential factor linking psoriasis to metabolic complications.
Exp Dermatol. 2014;23(6):438-40
Gerdes S, Osadtschy S, Buhles N, Baurecht H, Mrowietz U.
Cardiovascular biomarkers in patients with psoriasis.
Exp Dermatol. 2014;23(5):322-5


Gläser R, Gerdes S
Does the risk of cardiovascular complications decrease in psoriatic patients receiving systemic therapy?
Hautarzt 2013;64:63-64
Wohlrab J, Fiedler G, Gerdes S, Nast A, Philipp S, Radtke MA, Thaci D, Koening W, Pfeiffer AF, Härter M, Schön MP
Recommendations for detection of individual risk for comorbidities in patients with psoriasis.
Arch Dermatol Res 2013;305(2):91-98


Gerdes S, Osadtschy S, Rostami-Yazdi M, Buhles N, Weichenthal M, Mrowietz U.
Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Exp Dermatol. 2012;21(1):43-7
Gerdes S, Mrowietz U
Comorbidities and psoriasis. Impact on clinical practice
Hautarzt 2012;63(3):202-213
Gerdes S, Osadtschy S, Buhles N, Mrowietz U
Zonulin may not be a marker of autoimmunity in patients with psoriasis
Acta Derm Venereol. 2012;92(2):171-2
Han R, Rostami-Yazdi M, Gerdes S, Mrowietz U
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.
Br J Clin Pharmacol. 2012;74(3):424-36
Philipp S, Wilsmann-Theis D, Weyergraf A, Rotterdam S, Frambach Y, Gerdes S, Mössner R
Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
J Dtsch Dermatol Ges. 2012;10(11):827-37
Egberts F, Kotthoff AM, Gerdes S, Egberts JH, Weichenthal M, Hauschild A
Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Eur J Cancer 2012;48(5): 695-702


Gerdes S, Rostami-Yazdi M, Mrowietz U.
Adipokines and psoriasis.
Exp Dermatol. 2011;20(2):81-7
Gerdes S, Domm S, Mrowietz U.
Long-Term Treatment with Fumaric Acid Esters in an 11-Year-Old Male Child with Psoriasis.
Dermatology 2011;222(3):198-200


Gerdes S, Franke J, Domm S, Mrowietz U.
Ustekinumab in the treatment of palmoplantar pustulosis.
Br J Dermatol. 2010;im Druck
Gerdes S, Mrowietz U
Psoriasis im Kindesalter. Optionen der systemischen Therapie.
Der Deutsche Dermatologe 2010;(9): 572-576
Gerdes S, Zahl VA, Weichenthal M, Mrowietz U.
Smoking and alcohol intake in severely affected patients with psoriasis in Germany.
Dermatology 2010;220(1):38-43


Gerdes S, Kurrat W, Mrowietz U.
Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Br J Dermatol. 2009;160(4): 736-40
Gerdes S, Zahl VA, Weichenthal M, Mrowietz U
Smoking and alcohol intake in severely affected patients with psoriasis in Germany
Dermatology 2009;Dec 9
Gerdes, S., Mrowietz, U.
Impact of Comorbidities on the Management of Psoriasis.
In: Yawalkar N (ed): Management of Psoriasis. Curr Probl Dermatol. Basel, Karger, 2009;38, pp 21-36


Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U
Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis.
Br J Dermatol 2008;159(5):1116-23


Gerdes S, Shakery K, Mrowietz U.
Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
Br J Dermatol. 2007;156(5):838-42
Gerdes S, Mrowietz, U
Hilfe von außen bei Schuppenflechte. Topische Therapie der Psoriasis vulgaris.
CME 2007;4(6): 40-47


Gerdes S, Mrowietz U.
Follicular rash during therapy with erlotinib (Tarceva).
J Dtsch Dermatol Ges 2006;4:855-857
Gerdes S, Mrowietz U.
Classical topical therapy of psoriasis]
Hautarzt 2006;57:666-671


Keine Einträge


Keine Einträge


Keine Einträge


Keine Einträge




Praktikum Dermatologie

Dermatologie für das Sommersemester 2021

Informationen zur Durchführung unter den Bedingungen der Virusepidemie fienden Sie -> HIER  

Dermatologie für Zahnmediziner

Dermatologie für Zahnmediziner Sommersemester 2021

Informationen zur Durchführung unter den Bedingungen der Virusepidemie folgen.. 


Die Seite wurde zuletzt am 11.05.2021 um 07:58 geändert.